Angelika Pieper
About Angelika Pieper
Angelika Pieper is the Country Medical Director for Germany at BeiGene, with over 25 years of experience in the pharmaceutical and biotechnology industries.
Title and Current Roles
Angelika Pieper is the Country Medical Director for Germany at BeiGene. She also holds positions as Medical Director DACH at Clovis Oncology in Munich, Bavaria, Germany, and as Senior Medical Director DACH and Poland at Jazz Pharmaceuticals. Her current roles emphasize her extensive experience and leadership in the pharmaceutical industry.
Previous Experience in Pharmaceutical Industry
Angelika Pieper's career spans over 25 years in the pharmaceutical and biotechnology industries. She has worked for notable companies such as Jazz Pharmaceuticals, EUSA Pharma (a division of Jazz Pharmaceuticals), Celgene, Sandoz, Mundipharma, and Elan/Zeneus/Cephalon Europe. Her roles have included positions such as International Medical Director and Director EMEA Marketing for new indications.
Educational Background
Angelika Pieper achieved her Doctor of Medicine (Doctorates) from the University Hospital Munich Grosshadern. Her medical education laid the foundation for her substantial career in the pharmaceutical sector, equipping her with the knowledge and skills necessary for her various leadership roles.
Leadership Roles and Responsibilities
Angelika Pieper has held several significant leadership roles throughout her career. At Ribosepharm, she was responsible for both medical and marketing functions. She worked on global product management for oncology drugs Targretin and Ontak at Elan/Zeneus/Cephalon Europe and led European marketing efforts for oncology at Mundipharma. Additionally, she has served as Global Head of Marketing for Biopharmaceuticals at Sandoz and directed EMEA marketing for new indications at Celgene.
International Experience
Over her career, Angelika Pieper has gained extensive international experience. She has worked in multiple countries, including Germany, Switzerland, Ireland, and the United Kingdom. Her roles have often covered broad regions such as DACH and Poland, reflecting her capacity for handling diverse and complex markets. This international perspective has been a critical asset in her various senior medical and marketing director positions.